C85.18
Unspecified B-cell lymphoma, lymph nodes of multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Unspecified B-cell lymphoma affecting multiple lymph nodes is a type of non-Hodgkin lymphoma that originates from B cells, a crucial part of the immune system. When it involves several lymph node regions across the body, it can impact overall health and immune function. This condition is classified under ICD-10 code C85.18, which indicates an unspecified type of B-cell lymphoma with widespread lymph node involvement. Understanding this diagnosis helps patients and caregivers comprehend the condition, its possible causes, symptoms, and treatment options. It's important to note that lymphoma is a complex disease, and like all medical conditions, it requires evaluation by healthcare professionals for accurate diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic mutations that lead to abnormal B cell growth Immune system deficiencies Infections such as certain viruses (e.g., Epstein-Barr virus, HIV) Exposure to certain chemicals or radiation Older age, as risk increases with advancing years
Key Symptoms: Swelling of lymph nodes that may be painless Persistent fatigue and weakness Unexplained weight loss Fever and night sweats Itching over large areas of skin Shortness of breath or cough if chest lymph nodes are affected Abdominal pain or swelling if abdominal lymph nodes are involved
Diagnostic & Treatment
Diagnosis Path: Diagnosing this condition involves a combination of clinical evaluation and diagnostic tests, including: - Physical examination to identify swollen lymph nodes - Imaging studies such as CT scans or PET scans to determine the extent of lymph node involvement - Biopsy of affected lymph nodes to examine cellular characteristics - Laboratory tests including blood counts and markers - Bone marrow biopsy in some cases to assess for spreading Accurate diagnosis is essential for guiding appropriate treatment options.
Treatment Protocols: Treatment strategies are tailored to individual cases based on the stage and overall health, and may include: - Chemotherapy to destroy cancerous cells - Targeted therapy aimed at specific molecules involved in tumor growth - Immunotherapy to boost the immune system's response - Radiation therapy for localized disease - Stem cell transplant in cases with advanced or refractory disease Patients are managed by hematologists and oncologists, who monitor response to therapy and adjust treatment plans accordingly.
Clinical Advice & FAQs
Billing Guidance
Is C85.18 a billable ICD-10 code?
Yes, C85.18 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C85.18?
Clinical documentation must specify the nature of Unspecified B-cell lymphoma, lymph nodes of multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference